“When we elect our lawmakers in America, we
influence the moral character of this nation for better or for worse. When our laws permit violence against little
babies, incidents like the Columbine High School shootings are the logical outcome
…”
Rev. Frank Pavone, National Priests
for Life
|
The New Saint Joseph Baltimore Catechism (Official Baltimore Catechism
Series No. 2) Revised Edition
Order
securely online
This Catechism retains the text of the Revised Baltimore Catechism,
Number 2, but adds abundant explanations to help children understand the difficult parts
of each lesson along with pictures to aid in understanding.
Intended for grades 6-8
Official
Baltimore Catechism Series No. 1
is also available
Click Here
| |
Searle has objected to the use
Cytotec as the second part of the
abortion process involved
with RU 486.
|
|
| As reported by the Pro-Life Infonet following the FDA's
approval of RU 486, the drug company Searle has objected to the use of an ulcer-treating
drug (Cytotec) it makes being used as the second part of the abortion process involved
with RU 486. The first step of RU 486 is a drug used to kill the unborn child and Cytotec
(misoprostol) is then misused to induce a miscarriage of the aborted child. The following
is the text of the Searle letter objecting to the misuse of their drug.] August 23, 2000
Re:Cytotec (misoprostol) IMPORTANT DRUG WARNING CONCERNING UNAPPROVED USE OF INTRAVAGINAL
OR ORAL MISOPROSTOL IN PREGNANT WOMEN FOR INDUCTION OF LABOR OR ABORTION Dear Health Care
Provider: The purpose of this letter is to remind you that Cytotec administration by any
route is contraindicated in women who are pregnant because it can cause abortion. Cytotec
is not approved for the induction of labor or abortion. Cytotec is indicated for the
prevention of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)-induced
gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the
elderly and patients with concomitant debilitating disease, as well as patients at high
risk of developing gastric ulceration, such as patients with a history of ulcer. The
uterotonic effect of Cytotec is an inherent property of prostaglandin E1(PGE1), of which
Cytotec is stable, orally active, synthetic analog. Searle has become aware of some
instances where Cytotec, outside of its approved indication, was used as a cervical
ripening agent prior to termination of pregnancy, or for induction of labor, in spite of
the specific contraindications to its use during pregnancy. Serious adverse events
reported following off-label use of Cytotec in pregnant women include maternal or fetal
death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair,
hysterectomy or salpingo-oophorectomy; amniotic fluid embolism; severe vaginal bleeding,
retained placenta, shock, fetal bradycardia and pelvic pain. Searle has not conducted
research concerning the use of Cytotec for cervical ripening prior to termination of
pregnancy or for induction of labor, nor does Searle intend to study or support these
uses. Therefore, Searle is unable to provide complete risk information for Cytotec when it
is used for such purposes. In addition to the known and unknown acute risks to the mother
and fetus, the effect of Cytotec on the later growth, development and functional
maturation of the child when Cytotec is used for induction of labor or cervical ripening
has not been established. Searle promotes the use of Cytotec only for its approved
indication. Please read the enclosed updated complete Prescribing Information for Cytotec.
Further information may be obtained by calling 1-800-323-4204. Michael Cullen, MD Medical
Director, U.S. Searle 5200 Old Orchard Road Skokie, Illinois, 60077 Phone: (847) 982-7000
Fax: (847) 470-1480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This Page last updated: Tuesday, October 31, 2000
2978 people have visited this page
|
